D-1003-2020 Class II Terminated
FDA drug recall D-1003-2020 was initiated by American Health Packaging on Nov 20, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA. The recall status is terminated (terminated Aug 4, 2022). Affected quantity: 53,619 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 18, 2020
- Initiation Date
- Nov 20, 2019
- Termination Date
- Aug 4, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 53,619 cartons
Product description
Ranitidine Tablets, USP, 150 mg, 100 Tablets (10 tablets x 10 blister card), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-322-01; NDC Unit Dose Card: 60687-322-11
Reason for recall
CGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
Distribution pattern
Nationwide USA
Code information
Lot, expiry: Lots 179516, 179745, exp 12/31/2019; Lot 180712, exp 02/29/2020; Lot 180819, exp 04/30/2020; Lots 181403, 182544, 183155, 183236, exp 05/31/2020; Lots 185739, 186600, 186702, exp 12/31/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1003-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026